Vanguard Group’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300,819
Closed -$378K 4384
2025
Q2
$378K Hold
300,819
﹤0.01% 3984
2025
Q1
$325K Buy
300,819
+87,597
+41% +$144K ﹤0.01% 3981
2024
Q4
$429K Hold
213,222
﹤0.01% 3980
2024
Q3
$917K Buy
213,222
+1,175
+0.6% +$6.21K ﹤0.01% 3800
2024
Q2
$1.25M Buy
212,047
+205
+0.1% +$1.63K ﹤0.01% 3716
2024
Q1
$1.51M Buy
211,842
+362
+0.2% +$2.58K ﹤0.01% 3680
2023
Q4
$1.71M Buy
211,480
+29,731
+16% +$164K ﹤0.01% 3657
2023
Q3
$1.12M Sell
181,749
-409
-0.2% -$3K ﹤0.01% 3796
2023
Q2
$1.6M Buy
182,158
+6,950
+4% +$77.2K ﹤0.01% 3736
2023
Q1
$1.29M Hold
175,208
﹤0.01% 3838
2022
Q4
$1.42M Sell
175,208
-1,154
-0.7% -$12.5K ﹤0.01% 3792
2022
Q3
$2.36M Buy
176,362
+11,189
+7% +$172K ﹤0.01% 3683
2022
Q2
$2.69M Buy
165,173
+53,286
+48% +$882K ﹤0.01% 3677
2022
Q1
$2.55M Buy
111,887
+20,631
+23% +$370K ﹤0.01% 3863
2021
Q4
$2.13M Buy
91,256
+86
+0.1% +$3.46K ﹤0.01% 4011
2021
Q3
$5.37M Buy
91,170
+1,055
+1% +$76.5K ﹤0.01% 3611
2021
Q2
$8.26M Buy
90,115
+1,247
+1% +$166K ﹤0.01% 3310
2021
Q1
$12M Buy
88,868
+14,822
+20% +$1.79M ﹤0.01% 3057
2020
Q4
$8.21M Buy
74,046
+10,764
+17% +$1.16M ﹤0.01% 3094
2020
Q3
$5.99M Buy
63,282
+17,746
+39% +$1.81M ﹤0.01% 3057
2020
Q2
$5.29M Sell
45,536
-1,655
-4% -$161K ﹤0.01% 3068
2020
Q1
$3.9M Buy
47,191
+2,726
+6% +$299K ﹤0.01% 3075
2019
Q4
$5.44M Buy
44,465
+31,326
+238% +$2.66M ﹤0.01% 3142
2019
Q3
$985K Buy
13,139
+5,147
+64% +$380K ﹤0.01% 3655
2019
Q2
$538K Buy
+7,992
New +$848K ﹤0.01% 3812

Other funds holding HOOK

Vanguard Group's HOOK Position: Q3 2025 in Review

Vanguard Group sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 300,819 shares — an estimated $378K sold.

Vanguard Group first reported a position in HOOK in Q2 2019 and held it in 25 quarters. The position peaked at $12M in Q1 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • Vanguard Group reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • Vanguard Group sold 300,819 HOOKIPA Pharma shares in Q3 2025, an estimated $378K.
  • Vanguard Group first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 25 quarters.
  • Vanguard Group's HOOKIPA Pharma position peaked at $12M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Vanguard Group's 13F filing for Q3 2025, filed 7 Nov 2025.